The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

VOLUME 56 , ISSUE 4 ( October-December, 2014 ) > List of Articles

Original Article

A Study on Pulmonary Complications of Systemic Sclerosis in Eastern India

Avinandan Banerjee, Amlan Kanti Biswas

Keywords : Systemic sclerosis, Pulmonary hypertension, Interstitial lung disease

Citation Information : Banerjee A, Biswas AK. A Study on Pulmonary Complications of Systemic Sclerosis in Eastern India. Indian J Chest Dis Allied Sci 2014; 56 (4):231-235.

DOI: 10.5005/ijcdas-56-4-231

License: CC BY-NC 4.0

Published Online: 28-06-2022

Copyright Statement:  Copyright © 2014; The Author(s).


Aim. This study was undertaken to find out the characteristics of clinical, radiological and functional changes affecting the respiratory system in patients with systemic sclerosis (SSc) from eastern India, and the association of these characteristics with pulmonary hypertension. Methods. This was a cross-sectional, observational study involving 46 patients. Other than the routine tests, anti-nuclear antibody (ANA), spirometry, diffusing capacity of lung for carbon monoxide (DLCO) measurement, chest radiograph, highresolution computed tomography (HRCT) of thorax, 6-minute walk test and echocardiography were done. Results. Out of a total of 46 patients, 27 patients had diffuse cutaneous SSc (dcSSc) and 19 had limited cuteaneous SSc (lcSSc). Eleven patients had pulmonary hypertension. The HRCT revealed diffuse parenchymal lung disease (DPLD) in 32 (65%) cases. The ANA was positive in 83% cases. Anti-Scl70 was found in 41% of patients with dcSSc and anti-centromere antibody was found in 47% of patients with lcSSc. Spirometry revealed restrictive pattern in 30 patients; 9 had obstruction; and the rest were normal. The DLCO was abnormal in 38 patients. A strong correlation was found between reduction in DLCO and pulmonary artery systolic pressure (PASP). Also, a strong association was observed between a drop of > 4% in oxygen saturation on 6-minute walk test and presence of pulmonary arterial hypertension (PAH). Conclusions. Majority of the patients with SSc had restrictive lung disease with abnormal DLCO and features resembling non-specific interstitial pneumonia. Nucleolar ANA was predominantly found in patients having PAH. Presence of DPLD had a negative association with presence of anti-centromere antibody. Reduction in DLCO and a fall of > 4% in oxygen saturation on 6-minute walk test may be used as predictors of PAH in asymptomatic individuals.

PDF Share
  1. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
  2. Sharma VR, Trilokraj T, Khaitan BK, Krishna SM. Profile of systemic sclerosis intertiary care centre in North India. Indian J Dermatol Venerol Leprol 2006;72:416-20.
  3. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, et al. Scleroderma lung study (SLS): differences in presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis 2007;66:1641-7.
  4. Ghosh SK, Bandyopadhyay D, Saha I, Barua JK. Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from Eastern India. Indian J Dermatol 2012;57:201-5.
  5. Krishnamurthy V, Porkodi R, Ramakrishnan S, Rajendran CP, Madhavan R, Achuthan K, et al. Progressive systemicsclerosis in south India. J Assoc Physics India 1991;39:254-7.
  6. Kumar A, Malaviya AN, Tiwari SC, Singh RR, Kumar A, Pande JN. Clinical and laboratory profile of systemic sclerosis in northern India. J Assoc Physics India 1990;38:765-8.
  7. Medsger TA, Masi AT. The epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 1971;74:714-21.
  8. Kumar U, Ramteke R, Yadav R, Ramam M, Handa R, Kumar A. Prevalence and predictors of pulmonary arterial hypertension in systemic sclerosis. J Assoc Physics India 2008;56:413-7.
  9. Hunzelman N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, et al. The registry of the German Network of Systemic Sclroderma: frequency of disease subsets and patterns of organ involvement. Rheumatol (Oxford) 2008;47:1185-92.
  10. Strollo D, Goldin J. Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep 2010;12:156-61.
  11. Buch MH, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells AU, et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlation of 6 min walk test. Ann Rheum Dis 2007;66:169-173.
  12. Steen VD, Graham G, Conte C, Owens G, Medsger TA Jr. Isolated diffusion capacity reduction insystemic sclerosis. Arthritis Rheum 1992;35:765-70.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.